HCW Biologics Inc. Debt Instrument, Decrease, Forgiveness
HCW Biologics Inc. (HCWB) reported Debt Instrument, Decrease, Forgiveness of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-28.
Discontinued › Notes › Debt Instruments
us-gaap:DebtInstrumentDecreaseForgiveness · last filed 2023-03-28
- HCW Biologics Inc. debt instrument, decrease, forgiveness for the quarter ending 2022-12-31 was $0.00.
- HCW Biologics Inc. debt instrument, decrease, forgiveness for the quarter ending 2022-09-30 was $0.00.
- HCW Biologics Inc. debt instrument, decrease, forgiveness for the quarter ending 2021-12-31 was $0.00.
- HCW Biologics Inc. debt instrument, decrease, forgiveness for the quarter ending 2021-09-30 was $0.00.
- HCW Biologics Inc. debt instrument, decrease, forgiveness for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- HCW Biologics Inc. debt instrument, decrease, forgiveness for fiscal 2021 was $567.31K.
| Period end | Debt Instrument, Decrease, Forgiveness 3 month | Debt Instrument, Decrease, Forgiveness 6 month | Debt Instrument, Decrease, Forgiveness 9 month | Debt Instrument, Decrease, Forgiveness 12 month |
|---|---|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | $0.00 derived: sum of 2 quarters · filed 2023-03-28 | $0.00 10-K · filed 2023-03-28 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | $0.00 10-Q · filed 2022-11-07 | ||
| 2022-06-30 | $0.00 10-Q · filed 2022-08-12 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | $0.00 derived: sum of 2 quarters · filed 2023-03-28 | $0.00 derived: sum of 3 quarters · filed 2023-03-28 | $567.31K 10-K · filed 2023-03-28 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | $0.00 derived: sum of 2 quarters · filed 2022-11-07 | $567.31K 10-Q · filed 2022-11-07 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $567.31K 10-Q · filed 2022-08-12 | ||
| 2021-03-31 | $567.31K 10-Q · filed 2022-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |